Nuveen Asset Management, LLC Precision Biosciences Inc Transaction History

Nuveen Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $586,854 - $1.7 Million	-510,308 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $104,712 - $274,517	35,376 Added 7.45%	510,308 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $107,174 - $168,871	14,483 Added 3.15%	474,932 $3.52 Million
Q3 2021 Nov 12, 2021	BUY	$9.18 - $14.15 $2.72 Million - $4.19 Million	295,945 Added 179.9%	460,449 $5.31 Million
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $86,034 - $133,475	-10,661 Reduced 6.09%	164,504 $2.06 Million
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $187,717 - $345,864	21,904 Added 14.29%	175,165 $1.81 Million
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $309,859 - $646,145	-51,816 Reduced 25.27%	153,261 $1.28 Million
Q3 2020 Nov 16, 2020	BUY	$4.65 - $8.73 $3,873 - $7,272	833 Added 0.41%	205,077 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $88,502 - $165,230	18,992 Added 10.25%	204,244 $1.7 Million
Q1 2020 May 14, 2020	BUY	$5.05 - $15.01 $185,117 - $550,221	36,657 Added 24.67%	185,252 $1.12 Million
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $853,269 - $2.65 Million	135,011 Added 993.9%	148,595 $2.06 Million
Q2 2019 Aug 15, 2019	BUY	$11.88 - $16.94 $161,377 - $230,112	13,584 New	13,584 $180,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $842M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.